Eli Lilly’s $1,100 Target: Realistic or Risky?
Eli Lilly shares have surged 16% to $825 amid pharma sector optimism. But can the stock realistically reach $1,100? Our analysis examines the risks and market dynamics behind this ambitious target.
Eli Lilly shares have surged 16% to $825 amid pharma sector optimism. But can the stock realistically reach $1,100? Our analysis examines the risks and market dynamics behind this ambitious target.